ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,760.00
0.50%
S&P ASX All Technology
3,069.20
0.19%
Brent Oil
84.165
0.26%
US Dollar vs AUD
1.51332
0.17%
Bitcoin
62,917.99
-0.20%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pharming Group NV Leiden (PK) (PHGUF)

  7. Pharming Group NV Leiden (PK) (PHGUF) News

PHGUF

Pharming Group NV Leiden (PK) (PHGUF)

Pharming Group NV Leiden (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PHGUF
DateTimeSourceHeadlineSymbolCompany
15/12/202322:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
14/11/202301:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
26/09/202300:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
14/08/202322:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
10/08/202301:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
18/07/202320:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
01/06/202320:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
11/04/202322:58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
05/04/202320:57Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
28/03/202304:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
17/03/202301:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202322:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
13/03/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
22/02/202301:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
18/02/202302:41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
27/10/202221:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/08/202220:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
02/06/202222:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
19/05/202202:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
26/04/202221:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
07/04/202206:15Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
07/04/202206:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
06/01/202223:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
04/01/202223:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
29/10/202107:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PHGUFPharming Group NV Leiden (PK)
28/10/202122:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
22/10/202122:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
14/09/202123:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
10/08/202106:05Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PHGUFPharming Group NV Leiden (PK)
05/08/202121:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
 Showing the most relevant articles for your search:USOTC:PHGUF

Your Recent History

PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
ASX
SUN
Suncorp
NYSE
KO
Coca Cola
ASX
NCM
Newcrest Mining
ASX
RIO
Rio Tinto
ASX
XMM
S&P ASX 300 Metals and M...
ASX
WPL
Woodside Petroleum
NYSE
NKE
Nike
ASX
WDC
Westfield
NYSE
MCD
McDonalds
FX
GBPAUD
Sterling vs AUD
ASX
ORG
Origin Energy
ASX
XJO
S&P ASX 200
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved